Contract recognizes FloPatch’s unique potential to improve fluid management decisions and patient outcomes in sepsis care LOS ANGELES–(BUSINESS WIRE)–#flopatch–Flosonics Medical announced that its FloPatch wearable Doppler ultrasound device has received an Innovative Technology contract from Vizient®, the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded following review by hospital experts serving on … [Read more…]

Key Milestone Signals Readiness for Regulated Diagnostic Deployment GLASGOW, Scotland–(BUSINESS WIRE)–Dxcover, a global leader in AI-enabled technologies, today announced that its breakthrough liquid biopsy medical device has successfully achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746. “This validates not just a single product, but the underlying rigor of our infrastructure … [Read more…]

TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodiesterase-4 (PDE4) inhibitor, has been granted orphan medicinal product designation by the European Commission (EC) for the treatment of palmoplantar pustulosis (PPP). Palmoplantar pustulosis is a chronic inflammatory … [Read more…]

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Mike Fedock, executive vice president and chief financial officer, will speak at the Barclays 28th Annual Global Healthcare Conference on Thursday, March 12, … [Read more…]

2025 Total Revenue of $233.8 million, up 16% from 2024; 2025 Product Revenue of $206.1 million, up 14% from 2024 Strengthened Financial Foundation Through Strong Commercial Execution and Disciplined Operational Management CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) announced today financial results for its full year and fourth quarter ended December 31, 2025. “Our strong 2025 … [Read more…]

eyonis® LCS commercial launch is ongoing in U.S. following FDA 510(k) clearance CE-marking regulatory process is on-going with a decision expected in Q2 2026 that could trigger commercial rollout of eyonis® LCS across Europe this year Median eyonis® team will be at Booth #AI-16, AI Exhibition, Expo X1, to highlight clinical impact of eyonis® LCS … [Read more…]

Clinic provides behavioral health providers in Dallas to help residents heal DALLAS–(BUSINESS WIRE)–Serenity Mental Health Centers, a leader in psychiatric care and one of the fastest growing mental health providers in the nation, is one of the trusted behavioral health providers in Dallas, delivering personalized, evidence-based psychiatric services to support long-term wellness at its clinics … [Read more…]

– Milestone payments include $5.25 million cash and $2.25 million purchase of Precision stock– – Cash received supports Precision’s expected cash runway through 2028 and strategic focus on in vivo gene editing pipeline – DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop … [Read more…]

Radiobotics to join Medimaps Group, creating a global provider of AI-driven musculoskeletal (MSK) medical imaging software The transaction is expected to close following receipt of Danish foreign direct investment (FDI) approval and other customary closing conditions Together, they will bridge the gap between preventative bone health and acute trauma diagnostics, offering an expanded portfolio across … [Read more…]

— Proprietary In-Line Monitoring Technology Enables Seamless Scale-Up from Basic Research to Commercial Manufacturing — TOKYO–(BUSINESS WIRE)–PHC Corporation’s Biomedical Division (Head Office: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereinafter “PHCbi”), a global provider of laboratory sample storage and cell cultivation solutions and subsidiary of PHC Holdings Corporation (Head Office: Chiyoda-ku, Tokyo), today announced the launch of … [Read more…]